Recent Research | Page 8 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Date Journalsort descending Bone Marrow Disease
Thrombotic complications without evidence of hemolysis in paroxysmal nocturnal hemoglobinuria: is eculizumab indicated? Jul 2012 Ann Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Efficacy and safety of deferasirox in myelodysplastic syndromes Feb 2013 Ann Hematol myelodysplastic syndromes (MDS)
Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function Apr 2014 Ann Hematol myelodysplastic syndromes (MDS)
The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes. May 2013 Ann Hematol myelodysplastic syndromes (MDS)
Application of the revised International Prognostic Scoring System for myelodysplastic syndromes in Argentinean patients Jul 2013 Ann Hematol myelodysplastic syndromes (MDS)
Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability. May 2013 Ann Hematol myelodysplastic syndromes (MDS)
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab Jan 2017 Ann Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Asymptomatic cerebral bleeds in patients with aplastic anemia. Mar 2012 Ann Hematol aplastic anemia
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT Sep 2016 Ann Hematol myelodysplastic syndromes (MDS)
A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome. Apr 2012 Ann Hematol. aplastic anemia